| http://www.w3.org/ns/prov#value | - By technology, the market has segments Vaccines into - Live attenuated, inactivated, subunit, toxoid, conjugate, recombinant, and DNA. DNA vaccines demonstrate tremendous growth opportunities due to factors such as added thermo-stability, cost effectiveness and easy production, and rapid development against emerging diseases.
|
